Evidence map›Paper›PMID 42719573›Full record

ArticleFrontiers in surgery2026

Comprehensive analysis of prognostic factors and clinical implications of pneumonectomy for destroyed lung.

Shanbo Zheng, Akbar Anwar, Wancheng Zhong, Xiaogang Yan

Abstract read
In one paragraph

Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shanbo Zheng *Department of Thoracic Surgery, Xinjiang Uygur Autonomous Region Sixth People's Hospital, Urumqi, Xinjiang Uygur Autonomous Region, China.
Akbar Anwar *Department of Thoracic Surgery, Xinjiang Uygur Autonomous Region Sixth People's Hospital, Urumqi, Xinjiang Uygur Autonomous Region, China.
Wancheng ZhongDepartment of Thoracic Surgery, Xinjiang Uygur Autonomous Region Sixth People's Hospital, Urumqi, Xinjiang Uygur Autonomous Region, China.
Xiaogang YanDepartment of Thoracic Surgery, Xinjiang Uygur Autonomous Region Sixth People's Hospital, Urumqi, Xinjiang Uygur Autonomous Region, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evaluate the efficacy and safety of pneumonectomy in the treatment of destroyed lung caused by benign diseases, and identify the risk factors for postoperative complications. Methods: We retrospectively analyzed 158 patients with destroyed lung caused by benign diseases who underwent pneumonectomy in a single center from January 2014 to December 2024. Cases were assigned to tuberculosis (TB) group and non-tuberculosis (non-TB) group. Clinical characteristics and postoperative complications were analyzed and compared between groups. Univariate and multivariate analyses were performed to investigate the risk factors of pneumonectomy. Results: A total of 125 TB and 33 non-TB patients were included. All patients with preoperative hemoptysis recovered after surgery. Major postoperative complications were observed in 32 patients (20.3%), and perioperative deaths were noted in three patients (1.9%), who were from the TB group. The TB group had a longer duration of surgery and length of stay in the intensive care unit (ICU), a higher proportion of diabetes and postoperative complications (24.0% vs. 6.1%, Conclusion: Pneumonectomy is effective for destroyed lung caused by benign diseases. Patients with TB destroyed lung have a higher risk of postoperative complications. Controlling perioperative blood glucose and reducing duration of surgery may reduce the risk of perioperative complications.

Indexed as

destroyed lungpneumonectomypostoperative complicationprognostic factorpulmonary infectious diseases

Identifiers

PMID42719573
PMCPMC13554836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.